RALPH BHARATI: Open Payments
NPI 1851486294 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,894 in 168 payments from 21 companies in 2025. Trend: 2023 $2,225 · 2024 $11,569 · 2025 $3,894
Food & beverage: $3,890Education: $4
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $509 |
| Teva Pharmaceuticals USA, Inc. | 16 | $463 |
| ABBVIE INC. | 23 | $380 |
| Neurocrine BioSciences, Inc. | 19 | $365 |
| Alkermes, Inc. | 13 | $331 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $327 |
| Janssen Pharmaceuticals, Inc | 8 | $258 |
| Axsome Therapeutics, Inc. | 13 | $208 |
| Vanda Pharmaceuticals Inc. | 10 | $171 |
| Neuronetics, Inc. | 1 | $165 |
Products named: REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR, CAPLYTA, ARISTADA, INVEGA SUSTENNA, Auvelity.
Industry payments across KS — which companies pay providers there.
